A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings-Reference-Cited by-同舟云学术

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

Published:2010-11-11 Issue:2 Volume:60 Page:261-271
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Oudard Stéphane,Rixe Olivier,Beuselinck Benoit,Linassier Claude,Banu Eugeniu,Machiels Jean-Pascal,Baudard Marion,Ringeisen François,Velu Thierry,Lefrere-Belda Marie-Aude,Limacher Jean-Marc,Fridman W. H.,Azizi Michel,Acres Bruce,Tartour Eric

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-010-0935-9.pdf

Reference61 articles.

1. Wesseling J, van der Valk SW, Vos HL et al (1995) Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129:255–265

2. Brayman M, Thathiah A, Carson DD (2004) MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2:4

3. Hilkens J, Buijs F, Hilgers J et al (1984) Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 34:197–206

4. Leroy X, Zerimech F, Zini L et al (2002) MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am J Clin Pathol 118:47–51

5. Kraus S, Abel PD, Nachtmann C et al (2002) MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis. Hum Pathol 33:60–67

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy;Journal of Cancer;2024

2. A new frontier in cancer therapy: The intersection of cancer vaccines and metabolomics;Metabolomics for Personalized Vaccinology;2024

3. Antigenic targets in clear cell renal cell carcinoma;Kidney Cancer;2023-08-11

4. Immunotherapy and Cancer Stem Cells;Molecular Targets and Cancer Therapeutics (Part 2);2023-04-19

5. Armored modified vaccinia Ankara in cancer immunotherapy;Viral Vectors in Cancer Immunotherapy;2023